<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>biocompatible Archives - 3DHeals</title>
	<atom:link href="https://3dheals.com/tag/biocompatible/feed/" rel="self" type="application/rss+xml" />
	<link>https://3dheals.com/tag/biocompatible/</link>
	<description>Discover 3D Bioprinting and Healthcare Innovations</description>
	<lastBuildDate>Fri, 22 Apr 2022 07:12:23 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://3dheals.com/wp-content/uploads/2020/09/cropped-3D-final-icon-1-1-32x32.jpg</url>
	<title>biocompatible Archives - 3DHeals</title>
	<link>https://3dheals.com/tag/biocompatible/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Interview: Jon Rowley, Founder &#038; Chief Product Officer, RoosterBio</title>
		<link>https://3dheals.com/interview-jon-rowley-roosterbio/</link>
					<comments>https://3dheals.com/interview-jon-rowley-roosterbio/#respond</comments>
		
		<dc:creator><![CDATA[Jenny Chen, M.D.]]></dc:creator>
		<pubDate>Fri, 15 Mar 2019 18:04:05 +0000</pubDate>
				<category><![CDATA[Blog]]></category>
		<category><![CDATA[Influencer Interviews]]></category>
		<category><![CDATA[3dheals]]></category>
		<category><![CDATA[3dprinting]]></category>
		<category><![CDATA[biocompatible]]></category>
		<category><![CDATA[biofabrication]]></category>
		<category><![CDATA[bioprinting]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[stem cells]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=13126</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>I started my journey in 3D fabrication of living tissues during my University days.  I was getting my BS in Materials Science &#038; Engineering at Michigan when I fell in love with cell biology.  I ended up taking most of the classes within the Biology department even though it didn’t contribute to my degree – I just thought biology was an amazing field that I discovered a little too late to switch majors out of the Engineering school.  When I finally got to taking higher level Developmental Biology and Genetics classes, after taking all of these material processing classes in my engineering major, I started to look at living organisms simply as big material factories – making growth factors, cytokines, extracellular matrix or new cells when needed, on demand.  It was truly fascinating. This was around 1993-1994. As I was looking for what to study in Graduate School, this new field of Tissue Engineering was just starting to materialize, and Michigan hired its first faculty focused on this field named David Mooney out of MIT &#038; Harvard. I really hit it off with Dave and ended up staying at Michigan and doing my PhD in his lab where we focused on how material properties can be engineered for tissue engineering applications.  We collaborated a ton during those initial years on projects associated with designing biomaterials to guide cell function and tissue structure. I got to bring much of my materials processing background to the table and many of our inventions were immediately made into formats that could be tested in practical applications. We filed several patents during that time – one (in collaboration with Larry Bonassar – now at Cornell) titled Injection Molding of Living Tissues.  It was a really fun and exciting time to be in Tissue Engineering, as everything was so new. I have kept my love of the tissue engineering and biofabrication fields alive when I started my current company, RoosterBio.</p>
<p>The post <a href="https://3dheals.com/interview-jon-rowley-roosterbio/">Interview: Jon Rowley, Founder &#038; Chief Product Officer, RoosterBio</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>

<div class="wp-block-media-text alignwide is-stacked-on-mobile"><figure class="wp-block-media-text__media"><img fetchpriority="high" decoding="async" width="492" height="496" src="https://3dheals.com/wp-content/uploads/2018/12/Jon-Rowley-PhD.jpg" alt="Jon Rowley, Roosterbio" class="wp-image-12180 size-full" srcset="https://3dheals.com/wp-content/uploads/2018/12/Jon-Rowley-PhD.jpg 492w, https://3dheals.com/wp-content/uploads/2018/12/Jon-Rowley-PhD-100x100.jpg 100w, https://3dheals.com/wp-content/uploads/2018/12/Jon-Rowley-PhD-447x451.jpg 447w, https://3dheals.com/wp-content/uploads/2018/12/Jon-Rowley-PhD-150x150.jpg 150w, https://3dheals.com/wp-content/uploads/2018/12/Jon-Rowley-PhD-298x300.jpg 298w" sizes="(max-width: 492px) 100vw, 492px" /></figure><div class="wp-block-media-text__content">
<p class="has-large-font-size wp-block-paragraph"></p>
</div></div>



<p class="wp-block-paragraph"><strong><a href="https://www.linkedin.com/in/jonrowley/">Jon A. Rowley, Ph.D</a>.</strong>,&nbsp;is the Founder &amp; Chief Product Officer of <a href="https://3dheals.com/directory/name/RoosterBio/">RoosterBio</a> Inc.&nbsp; Jon started RoosterBio in 2013 as part of his personal quest of having the biggest impact possible on the commercial translation of technologies that incorporate living cells, including cellular therapies, engineered tissues, and tomorrow’s medical devices.&nbsp; Jon holds a Ph.D. from the University of Michigan in Biomedical Engineering and has authored over 35 peer-reviewed manuscripts and 20 issued or pending patents related to biomaterials development, tissue engineering, and cellular therapy.&nbsp; Jon started his industry career at BD as a scientist and R&amp;D manager in a Cell &amp; Tissue Technologies group focused on applying high throughput screening technologies to cell therapy media development and tissue engineering.&nbsp; Jon then contributed to the clinical development of Aastrom Biosciences’ Tissue Repair Cell product, where he was Sr Manager of Process Development responsible for manufacturing process improvements and cell delivery to the patient.&nbsp; Jon most recently spent 5 years as Director of Innovation and Process Development in Lonza’s Cell Therapy CMO business, and currently resides in Walkersville, MD with his wonderful wife and their three children. Jon will be a speaker at our upcoming <b>3DHEALS2020.</b></p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><strong>Jenny: When was the first encounter you had with 3D printing? What was that experience like? What were you thinking at that moment?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Rowley:</strong></span> My first encounter was during college at the University of Michigan where my undergraduate degree was in Materials Engineering in the early 1990s. &nbsp;I was getting exposed to all sorts of material processing technologies from metal forging to ceramic casting to fiber spinning and polymer injection molding. We even had access to an early SLA machine for rapid prototyping of computer-generated designs. During my undergraduate research work where I was developing applications for engineered protein polymers, the 3D fabrication technology that I utilized mostly was our departmental Scientific Glassblower, Harold. &nbsp;I would pop up to his workshop with custom cell culture tool concepts that I needed to be created, but I had the added complexity of needing the ability to steam sterilize the pieces (a process that melts most plastics). I was utilizing many types of materials processing in my work, and quickly realized the practical applications in the engineering world. </p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><strong>Jenny: What inspired you to start your journey in 3D bio-fabrication?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Rowley:</strong></span> I started my journey in the 3D bio-fabrication of living tissues during my University days. &nbsp;I was getting my BS in Materials Science &amp; Engineering at Michigan when I fell in love with cell biology. &nbsp;I ended up taking most of the classes within the Biology department even though it didn’t contribute to my degree – I just thought biology was an amazing field that I discovered a little too late to switch majors out of the Engineering school. &nbsp;When I finally got to taking higher level Developmental Biology and Genetics classes, after taking all of these material processing classes in my engineering major, I started to look at living organisms simply as big material factories – making growth factors, cytokines, extracellular matrix or new cells when needed, on demand. &nbsp;It was truly fascinating. This was around 1993-1994. As I was looking for what to study in Graduate School, this new field of Tissue Engineering was just starting to materialize, and Michigan hired its first faculty focused on this field named David Mooney out of MIT &amp; Harvard. I really hit it off with Dave and ended up staying at Michigan and doing my <g class="gr_ gr_22 gr-alert gr_gramm gr_inline_cards gr_disable_anim_appear Punctuation multiReplace" id="22" data-gr-id="22">PhD</g> in his lab where we focused on how material properties can be engineered for tissue engineering applications. &nbsp;We collaborated a ton during those initial years on projects associated with designing biomaterials to guide cell function and tissue structure. I got to bring much of my materials processing background to the table and many of our inventions were immediately made into formats that could be tested in practical applications. We filed several patents during that time – one (in collaboration with Larry Bonassar – now at Cornell) titled Injection Molding of Living Tissues. &nbsp;It was a really fun and exciting time to be in Tissue Engineering, as everything was so new. I have kept my love of the tissue engineering and biofabrication fields alive when I started my current company, RoosterBio.</p>



<p class="wp-block-paragraph"><strong>Jenny: Who inspired you the most along this journey in 3D printing bio-fabrication? </strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Rowley:</strong></span> I would say that my <g class="gr_ gr_28 gr-alert gr_gramm gr_inline_cards gr_run_anim Punctuation multiReplace" id="28" data-gr-id="28">PhD</g> advisor was the major inspiration when it came to solidifying my commitment to the <g class="gr_ gr_12 gr-alert gr_spell gr_inline_cards gr_run_anim ContextualSpelling" id="12" data-gr-id="12">biofabrication</g> and tissue engineering field. &nbsp;Dave Mooney was an inspiration on the technology, first and <g class="gr_ gr_9 gr-alert gr_spell gr_inline_cards gr_run_anim ContextualSpelling ins-del multiReplace" id="9" data-gr-id="9">formost</g>. But Dave also drove home many of the values that he picked up during his time working with his <g class="gr_ gr_29 gr-alert gr_gramm gr_inline_cards gr_run_anim Punctuation multiReplace" id="29" data-gr-id="29">PhD</g> co-advisors Bob Langer (an engineer) and Jay Vacanti (an MD). &nbsp;The key messages being that the field of tissue engineering and <g class="gr_ gr_10 gr-alert gr_spell gr_inline_cards gr_run_anim ContextualSpelling ins-del multiReplace" id="10" data-gr-id="10">biofabrication</g> are quite multidisciplinary, requiring experts in chemical engineering, materials science, cell biology, medicine <g class="gr_ gr_27 gr-alert gr_gramm gr_inline_cards gr_run_anim Punctuation only-ins replaceWithoutSep" id="27" data-gr-id="27">and</g> surgery. Achieving success in this field does require diverse teams that work together and are able to put egos aside to achieve what hasn’t been accomplished before. As the field of tissue engineering moves from a research-focused field towards a clinically- and commercially-focused field, then experts in software, production hardware (the 3D printers), cell production (the most critical raw material of engineered tissues and organs), biomaterial scaffolds/<g class="gr_ gr_11 gr-alert gr_spell gr_inline_cards gr_run_anim ContextualSpelling ins-del multiReplace" id="11" data-gr-id="11">bioinks</g>, and tissue biopreservation are all required to make the product, and experts in medicine, clinical trial design, quality and regulatory to get the product through the regulatory authorities. Working with diverse teams of people throughout <g class="gr_ gr_25 gr-alert gr_gramm gr_inline_cards gr_run_anim Grammar only-ins replaceWithoutSep" id="25" data-gr-id="25">industry</g> is what keeps things exciting and interesting for me.</p>



<p class="wp-block-paragraph"><span style="font-weight: 400;"><strong>Jenny: What motivates you the most for your work?</strong> </span></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Rowley:</strong></span> I have 3 things that tremendously motivate me:</p>



<p class="wp-block-paragraph"><span style="font-weight: 400;">Being in a position to truly impact the direction of a field is extremely motivating. The team at RoosterBio have established a new business model within the field that is removing multiple barriers to the commercial translation of 3D bio-fabricated products. &nbsp;As Alan Kay once said “The best way to predict the future is to invent it.”, and we are doing just that.</span></p>



<p class="wp-block-paragraph"><span style="font-weight: 400;">My wife and kids are a massive motivating factor for me – they are my biggest cheerleaders and the ones that keep me grounded in life – and help me make the most out of every day.</span></p>



<p class="wp-block-paragraph"><span style="font-weight: 400;">Lastly, the tremendous team of irrationally dedicated individuals at RoosterBio that work tirelessly to get our game changing products to market so that biofabrication technologies will impact human health at a faster pace – while having fun and supporting each other through our ups and downs. Seeing all of our hard work pay off is extremely motivating to me.</span></p>



<p class="wp-block-paragraph"><strong>Jenny: What is/are the biggest obstacle(s) in your line of work? If you have conquered them, what were your solutions?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Rowley</strong>:</span> As the only truly limited resource, using time to the fullest is something I’m always looking to do. Prioritization of opportunities is key – getting unfocused can be devastating for small businesses. The best, and really the only way, to conquer the obstacles that we face at RoosterBio is to focus our amazing team on specific challenges and let them work through the various problems together. Being such a multi-disciplinary company with challenging issues, it requires several experts to weigh in on before a solution emerges.</p>



<p class="wp-block-paragraph"><strong>Jenny: What do you think is (are) the biggest challenge(s) in 3D Printing/bio-printing? What do you think the potential solution(s) is (are)?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Rowley</strong>:</span> 3d printing of human tissues requires vast numbers of cells, at least hundreds of millions per tissue, and often billions to tens of billions to manufacture even small numbers of consistent tissue lots. &nbsp;Obtaining these cell numbers is both technically and economically challenging. <a href="https://3dheals.com/directory/name/RoosterBio/">RoosterBio</a> was founded to break down the technical and cost barrier of generating billions of cells, truly democratizing this piece of the <g class="gr_ gr_11 gr-alert gr_spell gr_inline_cards gr_run_anim ContextualSpelling ins-del multiReplace" id="11" data-gr-id="11">biofabrication</g> puzzle. &nbsp;We have radically simplified the production to the point that anyone can now generate vast quantities of high quality cells – getting more projects into development, into the clinic, and eventually onto the market.</p>



<p class="wp-block-paragraph"><strong>Jenny: What advice would you give to a smart driven college student in the “real world”? What bad <g class="gr_ gr_5 gr-alert gr_spell gr_inline_cards gr_run_anim ContextualSpelling ins-del multiReplace" id="5" data-gr-id="5">advices</g> you heard should they ignore?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Rowley:</strong></span> Perfect is the enemy of great – live by the 80:20 rule and get imperfect products out into the world for rapid feedback – and then build on the successes and know when to cut your losses and move on.</p>



<p class="wp-block-paragraph"><span style="font-weight: 400;">Advice to ignore: &nbsp;Many people don’t believe that innovation can be managed, or should be managed. They are wrong. There is a process to innovation that can be learned and implemented….. without proper oversight, almost everything will go off course. Learn how to manage, and everything will be OK. &nbsp;Not everything will work or be successful, but you greatly increase your chances of success with basic management principles.</span></p>



<p class="wp-block-paragraph"><strong>Jenny: If you could have a giant billboard to promote a message to millions and even billions of people in our community (i.e. healthcare 3D printing and bio-fabrication), what message would that be? </strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Rowley:</strong></span> “The best way to predict the future is the invent it.” Alan Kay. &nbsp;What this means to me is to go out and make things that fit into your world view – prove it can be done and more people will do it.</p>



<p class="wp-block-paragraph"><span style="font-weight: 400;"><strong>Jenny: What were/was the best investment you made in 3D printing/bio-printing/bio-fabrication?</strong></span></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Rowley:</strong></span> Easy: Starting <a href="https://3dheals.com/directory/name/RoosterBio/">RoosterBio</a>. The dividends from the learning I have had and the friendships I have started while building the RoosterBio business are immeasurable.</p>



<p class="wp-block-paragraph"><strong>Jenny: What were/was the worst investment you made in 3D printing/bio-printing/bio-fabrication? </strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Rowley:</strong></span> I bought a first version 3D printing pen at MakerFair way before they worked well…… it lasted a weekend.</p>



<p class="wp-block-paragraph"><strong>Jenny: What was/is the biggest risk you took in your career?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Rowley:</strong></span> Leaving a stable, established, good-paying job and cashing in my <g class="gr_ gr_10 gr-alert gr_gramm gr_inline_cards gr_run_anim Grammar multiReplace" id="10" data-gr-id="10">kids</g> college fund to start my own company was by far the biggest risk I have taken… and I would do it all over again even if RoosterBio had failed. &nbsp;Life is a journey, not a destination.</p>



<p class="wp-block-paragraph"><strong>Jenny: What do you enjoy in your spare time? What are you passionate about outside of your work/3d printing?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Rowley:</strong></span> I focus most of my time outside of RoosterBio with my wife and three grade school children – bringing up future scientist-engineers and teaching them to relish in nerdiness and “to be awesome always”.</p>



<p class="wp-block-paragraph"><strong>Jenny: What does the word “3DHEALS” mean to you? &nbsp;=)</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Rowley:</strong></span> Biofabrication of medical products is central to the success of Regenerative Medicine. Let’s stop treating disease, and start curing them!</p>



<figure class="wp-block-embed is-type-rich is-provider-3-dheals"><div class="wp-block-embed__wrapper">
https://3dheals.com/3dheals-washington-d-c/
</div></figure>
<p>The post <a href="https://3dheals.com/interview-jon-rowley-roosterbio/">Interview: Jon Rowley, Founder &#038; Chief Product Officer, RoosterBio</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/interview-jon-rowley-roosterbio/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>New! 3DHEALS White Paper &#8211; Biocompatible materials for 3D Printing Medical Device</title>
		<link>https://3dheals.com/new-white-paper-biocompatible-materials-3dprinting-medical-device/</link>
					<comments>https://3dheals.com/new-white-paper-biocompatible-materials-3dprinting-medical-device/#respond</comments>
		
		<dc:creator><![CDATA[3DHEALS]]></dc:creator>
		<pubDate>Wed, 24 Jan 2018 18:02:08 +0000</pubDate>
				<category><![CDATA[Blog]]></category>
		<category><![CDATA[Expert's Corner]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[3dprinting]]></category>
		<category><![CDATA[additive manufacture]]></category>
		<category><![CDATA[ASTM]]></category>
		<category><![CDATA[biocompatibility]]></category>
		<category><![CDATA[biocompatible]]></category>
		<category><![CDATA[biocompatible material]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[ISO]]></category>
		<category><![CDATA[material science]]></category>
		<category><![CDATA[regulatory entities]]></category>
		<category><![CDATA[standards]]></category>
		<category><![CDATA[testing]]></category>
		<category><![CDATA[toxicity]]></category>
		<category><![CDATA[USP]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=6127</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>   The objectives of this white paper are to provide clarification and in-depth discussion of the topics below, which are critical elements to the additive manufacturing industry in healthcare:<br />
Definition of biocompatibility.<br />
Discussion on how biocompatibility is assessed within the current regulations of materials and medical devices by major regulatory agencies.<br />
Summary of how different regulatory agencies are managing the introduction of 3D printing into the healthcare space to date.<br />
List of major available biocompatibility materials and those in development.</p>
<p>The post <a href="https://3dheals.com/new-white-paper-biocompatible-materials-3dprinting-medical-device/">New! 3DHEALS White Paper &#8211; Biocompatible materials for 3D Printing Medical Device</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>

<p class="wp-block-paragraph"><strong><em>Want to write a piece for&nbsp;</em></strong><a href="https://3dheals.com/category/blog/experts"><strong><em>3DHEALS Expert Corner</em></strong></a><strong><em>? Email us: info@3dheals.com</em></strong></p>


<p>After 6 months of extensive research and interviews, 3DHEALS&nbsp;team is finally ready to publish this anticipated <strong>white paper</strong> explaining the complex world of biocompatible materials for 3D printing/ 3D printed medical devices.</p>
<p>While many have recognized and advocated the vast potential of 3D printing technology in healthcare, based on recent survey results, hesitance is palpable within the ecosystem, ranging from 3D printing entrepreneurs, device makers, healthcare organizations, to other corporations in the healthcare field. Part of this uncertainty comes from the fact that 3D printing is a relatively new and different manufacturing process from traditional ones and the existing biocompatible materials used for traditional manufacturing processes may not demonstrate similar behaviors if translated for use in 3D printing. For example, in the 3D printing manufacturing process of metal powders, there is partial re-melting and solidification of the initial powder that may change the material physical and/or chemical properties of the printed object. Also, because of the added structural complexity (often an advantage of 3D printing), the behaviors of the final device are also not well known and need to be validated for both “safety” and “effectiveness”. Another example is the 3D printing of objects with non-solid fill (e.g., a honeycomb fill) has been used to decrease their weight and create structures that more closely mimic biological materials (e.g., the internal structure of bone). The cleaning of these complex geometries and the gas or liquid within these structures needs to be evaluated for safety during the regulatory process of a medical device.<br>The objectives of this white paper are to provide clarification and in-depth discussion of the topics below, which are critical elements to the additive manufacturing industry in healthcare:&nbsp;</p>
<p>Definition of biocompatibility.<br>Discussion on how biocompatibility is assessed within the current regulations of materials and medical devices by major regulatory agencies.<br>Summary of how different regulatory agencies are managing the introduction of 3D printing into the healthcare space to date.<br>List of major available biocompatibility materials and those in development.We are open to feedback and suggestions for a future edition. We are very honored and excited to be part of this innovative journey.</p>
<p>Buy Now.&nbsp;</p>
<p><img decoding="async" class="alignnone size-medium wp-image-6118" src="https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.31-PM-212x300.png" alt="" width="212" height="300" srcset="https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.31-PM-212x300.png 212w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.31-PM-447x634.png 447w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.31-PM-768x1088.png 768w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.31-PM-722x1024.png 722w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.31-PM-510x723.png 510w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.31-PM.png 652w" sizes="(max-width: 212px) 100vw, 212px" /><img decoding="async" class="alignnone size-medium wp-image-6119" src="https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.19-PM-213x300.png" alt="" width="213" height="300" srcset="https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.19-PM-213x300.png 213w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.19-PM-447x631.png 447w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.19-PM-768x1084.png 768w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.19-PM-726x1024.png 726w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.19-PM-510x720.png 510w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.19-PM.png 655w" sizes="(max-width: 213px) 100vw, 213px" /><img loading="lazy" decoding="async" class="alignnone size-medium wp-image-6117" src="https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.46-PM-210x300.png" alt="" width="210" height="300" srcset="https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.46-PM-210x300.png 210w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.46-PM-447x637.png 447w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.46-PM-768x1095.png 768w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.46-PM-718x1024.png 718w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.46-PM-510x727.png 510w, https://3dheals.com/wp-content/uploads/2018/01/Screen-Shot-2018-01-27-at-5.32.46-PM.png 776w" sizes="auto, (max-width: 210px) 100vw, 210px" /></p><p>The post <a href="https://3dheals.com/new-white-paper-biocompatible-materials-3dprinting-medical-device/">New! 3DHEALS White Paper &#8211; Biocompatible materials for 3D Printing Medical Device</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/new-white-paper-biocompatible-materials-3dprinting-medical-device/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Biocompatibility in Additive Manufacture: What’s hype, what’s real, and what’s important.</title>
		<link>https://3dheals.com/biocompatibility-in-additive-manufacture/</link>
					<comments>https://3dheals.com/biocompatibility-in-additive-manufacture/#comments</comments>
		
		<dc:creator><![CDATA[3DHEALS]]></dc:creator>
		<pubDate>Sun, 23 Apr 2017 22:33:56 +0000</pubDate>
				<category><![CDATA[3D Printing Medical]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Healthcare 3D Printing Community]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[biocompatible]]></category>
		<category><![CDATA[Engineering]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=2491</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>Author: Steven K. Pollack, Ph.D. (Carbon,&#160;Inc.) “First, a little about myself. I am currently a Research Scientist at Carbon, Inc. a Silicon Valley-based additive manufacturing company. Carbon brings both a unique approach to traditional SLA-type polymer printing and a family of resins with true engineering properties. Prior to joining Carbon, I was Director of the [&#8230;]</p>
<p>The post <a href="https://3dheals.com/biocompatibility-in-additive-manufacture/">Biocompatibility in Additive Manufacture: What’s hype, what’s real, and what’s important.</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<h3 id="dfd4" class="graf graf--h3 graf-after--h3">Author: <a class="markup--anchor markup--h3-anchor" href="https://www.linkedin.com/in/steven-pollack-a9763a12/" target="_blank" rel="nofollow noopener" data-href="https://www.linkedin.com/in/steven-pollack-a9763a12/">Steven K. Pollack, Ph.D.</a> (<a class="markup--anchor markup--h3-anchor" href="http://www.carbon3d.com/" target="_blank" rel="nofollow noopener" data-href="http://www.carbon3d.com/">Carbon</a>,&nbsp;Inc.)</h3>
<p><img loading="lazy" decoding="async" class="alignnone size-medium wp-image-2495" src="https://3dheals.com/wp-content/uploads/2017/04/Steven-K.-Pollack-300x300.jpeg" alt="" width="300" height="300" srcset="https://3dheals.com/wp-content/uploads/2017/04/Steven-K.-Pollack-300x300.jpeg 300w, https://3dheals.com/wp-content/uploads/2017/04/Steven-K.-Pollack-245x245.jpeg 245w, https://3dheals.com/wp-content/uploads/2017/04/Steven-K.-Pollack-100x100.jpeg 100w, https://3dheals.com/wp-content/uploads/2017/04/Steven-K.-Pollack-150x150.jpeg 150w, https://3dheals.com/wp-content/uploads/2017/04/Steven-K.-Pollack.jpeg 366w" sizes="auto, (max-width: 300px) 100vw, 300px" /></p>
<blockquote><p>“First, a little about myself. I am currently a Research Scientist at Carbon, Inc. a Silicon Valley-based additive manufacturing company. Carbon brings both a unique approach to traditional SLA-type polymer printing and a family of resins with true engineering properties. Prior to joining Carbon, I was Director of the Office of Science and Engineering Laboratories at the FDA’s Center for Devices and Radiological Health. One of my key roles was working to have the Agency understand the ramifications and opportunities additive manufacture bring to the development of Medical Therapies. My role at Carbon is in the technical and regulatory aspects of the use of our materials and printers in the Life Sciences and working with companies to realize those opportunities. The most common question we are asked is “do you have a biocompatible resin?” This short piece is to help clarify what that does and does not mean.”</p></blockquote>
<p id="a8e3" class="graf graf--p graf--hasDropCapModel graf--hasDropCap graf-after--figure"><span class="graf-dropCap">B</span>iocompatibility is a term the FDA uses to signify a set of tests (described by the international standards ISO 10993) that assure that a final medical device will be safe and effective for its indicated use. Therapeutic compatibility of a material (usually referred to as USP VI) has to do with whether a material used in the manufacture, storage and delivery of pharmaceutical and biological will not negatively impact the therapeutic or the patient. This blog will focuses on medical devices. The FDA Center for Devices and Radiological Health follows a guidance (<a class="markup--anchor markup--p-anchor" href="https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm348890.pdf" target="_blank" rel="nofollow noopener" data-href="https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm348890.pdf">https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm348890.pdf</a>), which relates the level of sophistication (and cost) of these tests to the anticipated risk. At a minimum, tests for cytotoxicity (local cell damage), dermal irritation (local inflammation) and sensitization (a developed allergic response) are required. If the device spends more that 24 hours in contact, further tests on systemic toxicity, genetic toxicity (related to potential to cause cancer) are required.</p>
<p id="ff9a" class="graf graf--p graf-after--p">The phrase “FDA Approved” often shows up in marketing for 3D printing materials. With the exception of certain classes of materials used in dentistry, FDA does <strong class="markup--strong markup--p-strong">not</strong> regulate materials and does <strong class="markup--strong markup--p-strong">not</strong> confer any certification for materials. If a provider of 3D printing resins submits their materials for these tests, they are in a position to assure a buyer that they have a good stating place from which to work from. But stating that they have any stamp of approval from the FDA is purely marketing.</p>
<p id="5294" class="graf graf--p graf-after--p">Materials used for denture bases, surgical guides, splints, orthodontic devices, sleep apnea and anti-bruxing devices (to prevent teeth grinding) are directly regulated. For short term contact (like surgical guides), the bar for testing is relatively low, and the material can go to market with very little cost to the manufacturer. For repeated use and prolonged contact time (&gt; 24 hours), more extensive tests are required and the manufacturer/distributer of these resins is required to obtain a 510(k) document to legally market their product in the US.</p>
<p><img loading="lazy" decoding="async" class="size-medium wp-image-2492 aligncenter" src="https://3dheals.com/wp-content/uploads/2017/04/Rodion-Kutsaev-225x300.jpeg" alt="" width="225" height="300" srcset="https://3dheals.com/wp-content/uploads/2017/04/Rodion-Kutsaev-225x300.jpeg 225w, https://3dheals.com/wp-content/uploads/2017/04/Rodion-Kutsaev-447x596.jpeg 447w, https://3dheals.com/wp-content/uploads/2017/04/Rodion-Kutsaev-510x680.jpeg 510w, https://3dheals.com/wp-content/uploads/2017/04/Rodion-Kutsaev.jpeg 600w" sizes="auto, (max-width: 225px) 100vw, 225px" /></p>
<p class="graf graf--p" style="text-align: center;">Photo Credit: Rodion&nbsp;Kutsaev</p>
<p class="graf graf--p" style="text-align: left;">&nbsp;</p>
<p class="graf graf--p" style="text-align: left;">Put simply, these tests answer the question “will anything in the product do harm. “ These tests are both chemical and biological. For traditional manufacturing materials, the FDA reviewers will have had extensive experience with materials, but biocompatibility testing of just the resin will typically be insufficient for the FDA reviewers, as subsequent manufacturing process can potentially introduce new contaminants that could be harmful. For 3D printing, the FDA experience is limited and the agency has put forth relatively conservative guidance on what manufacturers using 3D printing will be expected to do to assure the safely of the device (<a class="markup--anchor markup--p-anchor" href="https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM499809.pdf" target="_blank" rel="nofollow noopener" data-href="https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM499809.pdf">https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM499809.pdf</a>). This guidance is still in draft form and as such is only a glimpse into the thinking of the Agency. It addresses the printing process, post-processing, formulation of resins and any software changes that effects the physical and chemical properties of the final printed object.</p>
<p class="graf graf--p" style="text-align: left;">The bottom line is that the ultimate responsibility for the safely of most materials lies with the end-manufacturer. For most applications, this is the end-user of the printers. In the case of dental materials, it’s the printer manufactures and/or their suppliers. Carbon and many other providers of resins for additive manufacture gather biocompatibility data to provide a starting point and level of assurance that the use of our product will service to improve patients health.</p>
<p class="graf graf--p" style="text-align: left;"><img loading="lazy" decoding="async" class="alignnone" src="https://3dheals.com/wp-content/uploads/2017/03/All-Speakers.jpg" alt="" width="1920" height="1427"></p>
<p>&nbsp;</p>
<p>The post <a href="https://3dheals.com/biocompatibility-in-additive-manufacture/">Biocompatibility in Additive Manufacture: What’s hype, what’s real, and what’s important.</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/biocompatibility-in-additive-manufacture/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
		<item>
		<title>Product Liability : Biocompatible Materials in 3D Printed Products</title>
		<link>https://3dheals.com/biocompatible-materials-in-3d-printed-products/</link>
					<comments>https://3dheals.com/biocompatible-materials-in-3d-printed-products/#comments</comments>
		
		<dc:creator><![CDATA[Farah Tabibkhoei]]></dc:creator>
		<pubDate>Sun, 27 Nov 2016 10:23:11 +0000</pubDate>
				<category><![CDATA[Blog]]></category>
		<category><![CDATA[Expert's Corner]]></category>
		<category><![CDATA[Healthcare 3D Printing Community]]></category>
		<category><![CDATA[Legal]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[additive manufacture]]></category>
		<category><![CDATA[biocompatible]]></category>
		<category><![CDATA[bioprinting]]></category>
		<category><![CDATA[crown]]></category>
		<category><![CDATA[dental crown]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[FDA guidance]]></category>
		<category><![CDATA[FDA recommendation]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[material]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[reedandsmith]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Vertex Dental]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=1456</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>Want to write a piece for&#160;3DHEALS Expert Corner? Email us: info@3dheals.com As companies continue to innovate, they are turning to 3D printing technology to build customized, patient-matched 3D printed dental and medical devices that incorporate biocompatible materials. Advances in 3D printing technology have made it possible to print human tissue using a combination of stem [&#8230;]</p>
<p>The post <a href="https://3dheals.com/biocompatible-materials-in-3d-printed-products/">Product Liability : Biocompatible Materials in 3D Printed Products</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>

<p class="wp-block-paragraph"><strong><em>Want to write a piece for&nbsp;</em></strong><a href="https://3dheals.com/category/blog/experts"><strong><em>3DHEALS Expert Corner</em></strong></a><strong><em>? Email us: info@3dheals.com</em></strong></p>


<p>As companies continue to innovate, they are turning to 3D printing technology to build customized, patient-matched 3D printed dental and medical devices that incorporate biocompatible materials. Advances in 3D printing technology have made it possible to print human tissue using a combination of stem cells and biocompatible materials. Researchers are working on using 3D printing technology to print organs suitable for transplantation, with the goal of alleviating the shortage of donor organs and saving lives. Earlier this year, Vertex Dental, based in the Netherlands, developed the first CE Class IIa-certified materials, which are biocompatible, and approved for 3D printing dental applications such as dental splints, crowns, and bridges.<br>Biocompatible materials are not without risks. On June 16, 2016, the FDA issued a FDA Guidance entitled “Use of International Standard ISO 10993-1, ‘Biological evaluation of medical devices &#8211; Part 1: Evaluation and testing within a risk management process’” to assist manufacturers of devices that come into contact with the human body in evaluating the potential for an adverse biological response resulting from contact of component materials of the device with the body.<br>For suppliers of these component materials that are shipped to manufacturers to be integrated into end products used by patients, this raises the question of whether a component part supplier may be liable for injuries caused by defects in the end products. In other words, if a 3D printed device that comes into contact with a patient’s body causes an adverse reaction, can the supplier of the biocompatible material be held liable for defects in the finished product that incorporates the material?<br>In a decision published in May 2016, <em>Webb v. Electric Co.</em>, 63 Cal. 4th 167 (2016), the California Supreme Court explained that suppliers of component parts are not liable for injuries caused by a finished product unless (1) the component itself was defective and caused injury or (2) the supplier participated in integrating the component into a product and the integration caused the product to become defect and cause injury. The reasoning is that while component suppliers must adequately warn buyers (<em>e.g.,</em> manufacturers integrating the components into end products) of risks associated with the component, it is not reasonable to expect them to monitor all of the potential products that may incorporate their component part and all the potential risks associated with these finished products.<br><img loading="lazy" decoding="async" class="alignnone wp-image-1237" src="https://3dheals.com/wp-content/uploads/2016/08/legal3D-300x225.png" alt="Legal Issues of Healthcare 3D printing" width="459" height="344" data-id="1237" srcset="https://3dheals.com/wp-content/uploads/2016/08/legal3D-300x225.png 300w, https://3dheals.com/wp-content/uploads/2016/08/legal3D-447x335.png 447w, https://3dheals.com/wp-content/uploads/2016/08/legal3D-768x576.png 768w, https://3dheals.com/wp-content/uploads/2016/08/legal3D-1024x768.png 1024w, https://3dheals.com/wp-content/uploads/2016/08/legal3D-510x383.png 510w, https://3dheals.com/wp-content/uploads/2016/08/legal3D-1080x810.png 1080w, https://3dheals.com/wp-content/uploads/2016/08/legal3D.png 924w" sizes="auto, (max-width: 459px) 100vw, 459px" /><br>Furthermore, under the bulk supplier doctrine, where a raw material that is a component of a finished product, is supplied in bulk and intended for further processing (<em>e.g.</em>, heating, cooling, etc.), the raw materials supplier is not liable for harm caused by the defective design of a finished product. The rationale is that it would be overly burdensome to require raw materials suppliers to become experts on all of the end products in which the raw materials may be used and investigate the use of these materials by manufacturers over whom these suppliers do not exert control.<br>To mitigates risks of liability, materials suppliers should provide adequate warnings of the inherent risks associated with these component materials to the immediate purchaser of these products and take reasonable measures to ensure that appropriate warnings will be conveyed to those encountering these materials. Suppliers should also disclaim warranties about the suitability of the materials for use in end products. Additionally, suppliers should notify manufacturers that they are responsible for determining the suitability of the component materials for the devices they are manufacturing.</p>
<h2>About the Author :</h2>
<p><img loading="lazy" decoding="async" class="alignnone wp-image-1318 size-medium" src="https://3dheals.com/wp-content/uploads/2016/08/tabibkhoeif_hi-c-214x300.jpg" alt="tabibkhoei,f_hi-c" width="214" height="300" data-id="1318" srcset="https://3dheals.com/wp-content/uploads/2016/08/tabibkhoeif_hi-c-214x300.jpg 214w, https://3dheals.com/wp-content/uploads/2016/08/tabibkhoeif_hi-c-447x626.jpg 447w, https://3dheals.com/wp-content/uploads/2016/08/tabibkhoeif_hi-c-768x1075.jpg 768w, https://3dheals.com/wp-content/uploads/2016/08/tabibkhoeif_hi-c-731x1024.jpg 731w, https://3dheals.com/wp-content/uploads/2016/08/tabibkhoeif_hi-c-1080x1512.jpg 1080w, https://3dheals.com/wp-content/uploads/2016/08/tabibkhoeif_hi-c-510x714.jpg 510w, https://3dheals.com/wp-content/uploads/2016/08/tabibkhoeif_hi-c.jpg 660w" sizes="auto, (max-width: 214px) 100vw, 214px" /><br><a href="https://www.linkedin.com/in/farah-tabibkhoei-1b196b66"></a><br><strong>Farah Tabibkhoei</strong> is a member of the Complex Litigation Group at Reed Smith LLP.&nbsp; Her practice focuses on medical device product liability, managed care disputes, and 3D printing.&nbsp; Farah can be reached at FTabibkhoei@ReedSmith.com.</p><p>The post <a href="https://3dheals.com/biocompatible-materials-in-3d-printed-products/">Product Liability : Biocompatible Materials in 3D Printed Products</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/biocompatible-materials-in-3d-printed-products/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
	</channel>
</rss>
